近幾年如果有涉及共同侵權(divided infringement)的案子，幾乎都會以代表案例Akamai Techs., Inc. v. Limelight Networks, Inc. (Akamai案)所產生之標準予以審視，而Akamai案纏訟多年，共同侵權的判斷標準也隨著每次判決意見不斷改變，從2010年CAFC做出第一次判決(Akamai I)，中間打到最高法院後發回CAFC重審(Akamai III)，最後於2015年CAFC做出二次判決，其中第二次的全院庭審(en banc)之判決(Akamai V)意見被法律圈解釋為法院擴大了271(a)的適用範圍，換句話說，共同侵權似乎更容易成立了。
本次要探討的案例Medgraph, Inc. v. Medtronic, Inc., Case No. 15-2019 (Fed. Cir., Dec. 13, 2016)(Medgraph案)也與共同侵權有關。被告Medtronic製造與銷售多種整合糖尿病管理解決方案，包括用於糖尿病的CareLink治療管理系統(CareLink system)，其整合給病患使用的CareLink個人治療管理軟體(CareLink Personal)以及給健康照護專業人士使用的CareLink專業糖尿病治療管理軟體(CareLink Pro)。
Claims 1. A method for improving and facilitating diagnosis and treatment of patients having medical conditions requiring long-term profiles of specific variables, said method including the steps of
using at least one measuring device, periodically taking a measurement of at least one medically important variable that has been identified for a patient from a body of said patient;
ensuring said patient is separated from said at least one measuring device after taking each said measurement;
inputting said at least one medically important variable as raw data into a primary computer system after said step of ensuring said patient is separated and recording said raw data in a mass storage device integrated with said primary computer system;…
16. A system for improving and facilitating diagnosis and treatment of patients having medical conditions requiring long-term profiles of at least one predetermined medically important variable, comprising
means for inputting…whereby raw data can be communicated from a remote computer proximate a patient comprising an ordinary general purpose personal computer and from an ordinary telephone wherein data is transmitted…
沒有留言:
張貼留言